Clinical Trials Logo

Gynecologic Cancer clinical trials

View clinical trials related to Gynecologic Cancer.

Filter by:

NCT ID: NCT05313724 Recruiting - Gynecologic Cancer Clinical Trials

Mind-body Online Therapy in Gynecological Oncology

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

In this randomized-controlled two-arm monocentric study with three measurement time points, the effectiveness and feasibility of an internet-based, therapist-guided mind-body self-help intervention for gynecological cancer patients with primary diagnoses is examined. Different modules (e.g., relaxation, mindfulness, stress management, disease management, nutrition and exercise behaviors) with a mind-body focus are available for the patients. The goal of the intervention is to improve or maintain the quality of life.

NCT ID: NCT05313191 Recruiting - Breast Cancer Clinical Trials

Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors

ReRT
Start date: January 24, 2022
Phase: N/A
Study type: Interventional

The goal of this clinical research trial is to study the use of differing investigational doses and scheduling for Proton Therapy for tumors previously treated with radiation therapy. Generally, when patients are first treated for cancer with radiation therapy, they are treated with traditional photon (or x-ray) radiation therapy, which uses high-energy waves to kill tumor cells. In some cases, the cancer either returns or a new tumor can present in a different part of the body. With the usual radiation treatment, the photon beams travel all the way through the body. As a result, healthy tissues in front of and behind the tumor are exposed to radiation. Physicians who treat these cases where the tumor has returned often use a much lower dose of radiation to prevent patients from experiencing serious and long-term side-effects. This dose is often not strong enough to destroy the cancerous tumor. Alternatively, they may also treat a smaller area than would be indicated for complete tumor eradication, again in an attempt to prevent serious and long-term toxicities, but at the cost of optimally treating the cancer. Proton therapy, however, may offer a chance to safely deliver a more effective dose and volume of radiation as it is more targeted and can spare healthy tissues surrounding the tumor. The reason we are conducting this research study is to look at whether Proton therapy can be a better way to treat reoccurring tumors in patients who have previously received radiation therapy to the same area, compared to treatment approaches used to date.

NCT ID: NCT05296512 Recruiting - Gynecologic Cancer Clinical Trials

Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer

Start date: September 23, 2022
Phase: Phase 2
Study type: Interventional

This research study is being done to test the efficacy and safety of combining the study drugs pembrolizumab and lenvatinib in patients with clear cell ovarian cancer. The names of the study drugs involved in this study are: - Lenvatinib - Pembrolizumab

NCT ID: NCT05292859 Active, not recruiting - Colorectal Cancer Clinical Trials

Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

Start date: October 1, 2022
Phase:
Study type: Observational

Long-Term Follow-Up Study for Subjects Enrolled in the Phase I/II Study of Autologous T Cells Engineered using the Sleeping Beauty System to Express T cell Receptors (TCRs) Reactive Against Cancer-specific Mutations in Subjects with Solid Tumors

NCT ID: NCT05283460 Completed - Gynecologic Cancer Clinical Trials

The Effect of Mandala Activity on Life Satisfaction

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This study aimed to determine the effect of mandala activity on life satisfaction of women receiving chemotherapy for gynecological cancer.

NCT ID: NCT05242770 Completed - Gynecologic Cancer Clinical Trials

Pelvic Physical Therapy for Sexual Dysfunction in Gynecologic Oncology Survivors

Start date: March 28, 2022
Phase: N/A
Study type: Interventional

The purpose of this research study is to investigate the use of pelvic physical therapy for gynecologic cancer survivors who report sexual dysfunction. Physical therapy experts believe that a full 10-week regimen is necessary for true improvement of symptoms. Investigators aim to see if this tense regimen is feasible for survivors. Investigators also aim to see if patients have an improvement in their sexual function and quality of life.

NCT ID: NCT05220033 Recruiting - Ovarian Cancer Clinical Trials

Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer

Start date: July 14, 2020
Phase: N/A
Study type: Interventional

This study looks at how well the Journey Ahead intervention works in improving coping and communication skills in participants with gynecologic cancers.

NCT ID: NCT05210556 Active, not recruiting - Clinical trials for Surgical Site Infection

Oral Antibiotic Bowel Preparation in Gynecologic Oncology Surgery

Start date: December 22, 2021
Phase:
Study type: Observational

The purpose of this study is to investigate whether the use of a preoperative antibiotic bowel regimen is associated with a reduced risk of deep organ/space surgical site infection in gynecologic oncology surgery.

NCT ID: NCT05194735 Active, not recruiting - Colorectal Cancer Clinical Trials

Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors

Start date: April 4, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

A Phase I/II study of autologous T cells engineered using the Sleeping Beauty transposon/transposase system to express TCR(s) reactive against neoantigens in subjects with relapsed/refractory solid tumors

NCT ID: NCT05193357 Completed - Gynecologic Cancer Clinical Trials

Home-based Intermittent Pneumatic Compression Therapy for Gynecologic Cancer

Start date: March 7, 2019
Phase: N/A
Study type: Interventional

Investigators conducted a prospective study of cancer patients to investigate the efficacy, quality of life, satisfaction, and safety of a home-based intermittent pneumatic compression (IPC) device during the maintenance phase of lower extremity lymphedema. This device has a unique mode designed to mimic the manual lymphatic drainage (MLD) technique and thereby gently facilitate lymphatic draining of proximal extremities.